{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:15:27Z","timestamp":1788066927003,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,29]]},"DOI":"10.7759\/cureus.115416","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T04:19:02Z","timestamp":1788063542000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Uncertainty in Rapidly Progressive Brainstem Lesions: A Radiological Diagnosis of Probable CNS Relapse of Diffuse Large B-cell Lymphoma"],"prefix":"10.7759","author":[{"given":"Yik Shun Eason","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Santhosh Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Ibbeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li S","year":"2018","unstructured":"Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018, 50:74-87. 10.1016\/j.pathol.2017.09.006","journal-title":"Pathology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.6520","article-title":"CNS International Prognostic Index: a risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"34","author":"Schmitz N","year":"2016","unstructured":"Schmitz N, Zeynalova S, Nickelsen M, et al.. CNS International Prognostic Index: a risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol. 2016, 34:3150-6. 10.1200\/JCO.2015.65.6520","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00422","article-title":"Real-world data (RWD) on the 3-year follow-up outcomes of different CNS prophylaxis strategies across CNS-IPI risk groups in patients with diffuse large B-cell non-Hodgkin lymphoma","volume":"7","author":"Faqah A","year":"2021","unstructured":"Faqah A, Asif S, Goksu SY, Sheikh HS. Real-world data (RWD) on the 3-year follow-up outcomes of different CNS prophylaxis strategies across CNS-IPI risk groups in patients with diffuse large B-cell non-Hodgkin lymphoma. JCO Glob Oncol. 2021, 7:486-94. 10.1200\/GO.20.00422","journal-title":"JCO Glob Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-101402","article-title":"Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report","volume":"111","author":"Doolittle ND","year":"2008","unstructured":"Doolittle ND, Abrey LE, Shenkier TN, et al.. Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report. Blood. 2008, 111:1085-93. 10.1182\/blood-2007-07-101402","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-203353","article-title":"Primary central nervous system lymphoma presenting as choreoathetosis","volume":"2014","author":"Noda K","year":"2014","unstructured":"Noda K, Hattori N, Okuma Y. Primary central nervous system lymphoma presenting as choreoathetosis. BMJ Case Rep. 2014, 2014:10.1136\/bcr-2013-203353","journal-title":"BMJ Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.21030084","article-title":"Primary CNS lymphoma and secondary causes of mania: a case report and literature review","volume":"34","author":"Wang C","year":"2022","unstructured":"Wang C, Fipps DC. Primary CNS lymphoma and secondary causes of mania: a case report and literature review. J Neuropsychiatry Clin Neurosci. 2022, 34:84-8. 10.1176\/appi.neuropsych.21030084","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6569.2007.00231.x","article-title":"Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy","volume":"18","author":"Zacharia TT","year":"2008","unstructured":"Zacharia TT, Law M, Naidich TP, Leeds NE. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy. J Neuroimaging. 2008, 18:411-7. 10.1111\/j.1552-6569.2007.00231.x","journal-title":"J Neuroimaging"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1470-7330-14-22","article-title":"MR imaging features of intracranial primary CNS lymphoma in immune competent patients","volume":"14","author":"Mansour A","year":"2014","unstructured":"Mansour A, Qandeel M, Abdel-Razeq H, Abu Ali HA. MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging. 2014, 14:22. 10.1186\/1470-7330-14-22","journal-title":"Cancer Imaging"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00033","article-title":"Differential efficacy from the addition of bortezomib to R-CHOP in diffuse large B-cell lymphoma according to the molecular subgroup in the REMoDL-B study with a 5-year follow-up","volume":"41","author":"Davies AJ","year":"2023","unstructured":"Davies AJ, Barrans S, Stanton L, et al.. Differential efficacy from the addition of bortezomib to R-CHOP in diffuse large B-cell lymphoma according to the molecular subgroup in the REMoDL-B study with a 5-year follow-up. J Clin Oncol. 2023, 41:2718-23. 10.1200\/JCO.23.00033","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.25259\/JCIS_135_2021","article-title":"Different facets of intracranial central nervous system lymphoma and its imaging mimics","volume":"12","author":"Kwok HM","year":"2022","unstructured":"Kwok HM, Li KY, Chan RL, et al.. Different facets of intracranial central nervous system lymphoma and its imaging mimics. J Clin Imaging Sci. 2022, 12:4. 10.25259\/JCIS_135_2021","journal-title":"J Clin Imaging Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02371-y","article-title":"Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA\/ DSHNHL collaboration","volume":"38","author":"Frontzek F","year":"2024","unstructured":"Frontzek F, Renaud L, D\u00fchrsen U, et al.. Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA\/ DSHNHL collaboration. Leukemia. 2024, 38:2225-34. 10.1038\/s41375-024-02371-y","journal-title":"Leukemia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014404","article-title":"Incidence and characterization of secondary CNS lymphoma in 1972 patients with DLBCL: a Danish nationwide cohort study","volume":"9","author":"Tolley ER","year":"2025","unstructured":"Tolley ER, Nielsen TH, Hersby DS, et al.. Incidence and characterization of secondary CNS lymphoma in 1972 patients with DLBCL: a Danish nationwide cohort study. Blood Adv. 2025, 9:893-905. 10.1182\/bloodadvances.2024014404","journal-title":"Blood Adv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaf234","article-title":"Time matters: the prognostic impact of diagnostic delay on survival in primary central nervous system lymphoma-a single-center, retrospective real-world study","volume":"8","author":"Lehner L","year":"2026","unstructured":"Lehner L, von Baumgarten L, Reis J, et al.. Time matters: the prognostic impact of diagnostic delay on survival in primary central nervous system lymphoma-a single-center, retrospective real-world study. Neurooncol Adv. 2026, 8:vdaf234. 10.1093\/noajnl\/vdaf234","journal-title":"Neurooncol Adv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164745","article-title":"Prognostic impacts of age, diagnosis time, and relapses in primary CNS lymphoma","volume":"13","author":"Ohanyan S","year":"2024","unstructured":"Ohanyan S, Buxbaum C, Stein P, Ringelstein-Harlev S, Shelly S. Prognostic impacts of age, diagnosis time, and relapses in primary CNS lymphoma. J Clin Med. 2024, 13:10.3390\/jcm13164745","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025031455","article-title":"Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma","volume":"147","author":"Alderuccio JP","year":"2026","unstructured":"Alderuccio JP, Baggio D, Han S, et al.. Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma. Blood. 2026, 147:1814-27. 10.1182\/blood.2025031455","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00506-3","article-title":"Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse","volume":"11","author":"Bobillo S","year":"2021","unstructured":"Bobillo S, Joffe E, Sermer D, et al.. Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse. Blood Cancer J. 2021, 11:113. 10.1038\/s41408-021-00506-3","journal-title":"Blood Cancer J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17142352","article-title":"The diagnostic yield of cerebrospinal fluid analysis for the diagnosis of primary central nervous system lymphoma: a systematic review","volume":"17","author":"van Rooij JL","year":"2025","unstructured":"van Rooij JL, Snijders TJ, Bhande P, Seute T, Minnema MC, Wessels PH. The diagnostic yield of cerebrospinal fluid analysis for the diagnosis of primary central nervous system lymphoma: a systematic review. Cancers (Basel). 2025, 17:10.3390\/cancers17142352","journal-title":"Cancers (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15133","article-title":"Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma","volume":"112","author":"Yamagishi Y","year":"2021","unstructured":"Yamagishi Y, Sasaki N, Nakano Y, et al.. Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma. Cancer Sci. 2021, 112:4702-10. 10.1111\/cas.15133","journal-title":"Cancer Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15410","article-title":"Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review","volume":"182","author":"van Westrhenen A","year":"2018","unstructured":"van Westrhenen A, Smidt LC, Seute T, Nierkens S, Stork AC, Minnema MC, Snijders TJ. Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review. Br J Haematol. 2018, 182:384-403. 10.1111\/bjh.15410","journal-title":"Br J Haematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e14041","article-title":"Exploring the diagnostic potential of cerebrospinal fluid (CSF) IL- 10: IL-6 ratio in patients with primary central nervous system lymphoma (PCNSL)","volume":"42","author":"Singh S","year":"2024","unstructured":"Singh S, Kapila AT, Prakash G, Lal V, Gupta V, Minz RW, Mahesh KV. Exploring the diagnostic potential of cerebrospinal fluid (CSF) IL- 10: IL-6 ratio in patients with primary central nervous system lymphoma (PCNSL). J Clin Oncol. 2024, 42:e14041. 10.1200\/JCO.2024.42.16_suppl.e14041","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/520101-diagnostic-uncertainty-in-rapidly-progressive-brainstem-lesions-a-radiological-diagnosis-of-probable-cns-relapse-of-diffuse-large-b-cell-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T04:19:03Z","timestamp":1788063543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/520101-diagnostic-uncertainty-in-rapidly-progressive-brainstem-lesions-a-radiological-diagnosis-of-probable-cns-relapse-of-diffuse-large-b-cell-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.115416","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,29]]}}}